1397237-98-7 Usage
General Description
5-Bromo-4-fluoro-2-methoxybenzenamine is a chemical compound with the molecular formula C7H7BrFNO. It is a derivative of aniline and contains a bromine, fluorine, and methoxy group attached to a benzene ring. 5-Bromo-4-fluoro-2-methoxybenzenamine is used in the synthesis of pharmaceuticals and agrochemicals, and it has potential applications in the field of medicinal chemistry. It is also used as a building block in organic synthesis for the preparation of various biologically active molecules. Additionally, it has been studied for its potential use as a precursor in the development of new drug compounds. However, due to its potential health hazards, it should be handled and used with caution in a laboratory setting.
Check Digit Verification of cas no
The CAS Registry Mumber 1397237-98-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,9,7,2,3 and 7 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1397237-98:
(9*1)+(8*3)+(7*9)+(6*7)+(5*2)+(4*3)+(3*7)+(2*9)+(1*8)=207
207 % 10 = 7
So 1397237-98-7 is a valid CAS Registry Number.
1397237-98-7Relevant articles and documents
THERAPEUTIC COMPOUNDS AND METHODS OF USE
-
Paragraph 0612; 0615; 0616, (2021/05/21)
The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.
ACLY INHIBITORS AND USES THEREOF
-
Paragraph 00777, (2020/06/01)
The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.
7-HYDROXY-INDOLINYL ANTAGONISTS OF P2Y1 RECEPTOR
-
Paragraph 00200, (2014/02/16)
The present invention provides compounds of Formula (I): Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor which may be used medicaments.